Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 908 of 6351
-
Mysterious moments of clarity in severe dementia under scientific scrutiny
Knowledge-focused Recruiting nowCognitive decline in dementia is considered irreversible, however episodes of paradoxical lucidity (PL) in severe dementia suggest other mechanisms may be in play. Beyond anecdotal reports of transient PL events occurring in patients predominantly in late-stage dementia and typic…
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
New drug combo aims to wipe out bladder cancer before surgery
Disease control Recruiting nowThis study will test whether enfortumab vedotin combined with pembrolizumab is an effective treatment for people with bladder cancer (urothelial carcinoma) involving the lymph nodes who are going to have surgery to remove their cancer (cystectomy). The researchers will look at wh…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New drug cocktail targets rare lung cancer mutation in chinese patients
Disease control OngoingThis is a phase 2, multicenter, single-arm study with a safety lead-in to investigate the efficacy, safety and pharmacokinetics of encorafenib 450 mg once daily (QD) in combination with binimetinib 45 mg twice daily (BID) (Combo450) in adult Chinese participants with metastatic u…
Phase 2 • Sponsor: Pierre Fabre Medicament • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Immunotherapy duo shows promise for Tough-to-Treat uterine cancer
Disease control Recruiting nowThis phase II trial tests whether the combination of nivolumab and ipilimumab is better than nivolumab alone to shrink tumors in patients with deficient mismatch repair system (dMMR) endometrial carcinoma that has come back after a period of time during which the cancer could not…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New drug studied to reverse blood thinners during emergency bleeding
Disease control Recruiting nowThis survey will be conducted to investigate the status of occurrence of the safety specifications set for "Safety specification" in patients who received Ondexxya Intravenous Injection 200 mg. In addition, this survey will be implemented to understand the followings by collectin…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New combo therapy targets tough blood cancers in early trial
Disease control OngoingThis is a study to assess the safety of increasing dose levels of bexmarilimab when combined with standard of care (SoC) in patients with myelodysplastic syndrome (MDS) or chronic myelomonocytic leukemia (CMML) or acute myeloid leukemia (AML); Phase 1 aims to identify the recomme…
Phase 1/2 • Sponsor: Faron Pharmaceuticals Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo targets Gene-Mutated breast cancer after first treatment fails
Disease control OngoingThe study is a nationwide, multicenter single-arm phase 2 study. The current phase 2 study investigates the efficacy of the combination of fulvestrant and alpelisib directly after progression on fulvestrant (either in first or second line, with or without previous use of CDK4/6-i…
Phase 2 • Sponsor: Borstkanker Onderzoek Groep • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Broccoli compound may shield hearts from chemo damage
Disease control Recruiting nowCardiomyopathy is a major complication of doxorubicin (DOX) chemotherapy, and 10-21% of breast cancer patients receiving DOX experience compromised cardiac function. Recent advancements have increased cancer survivorship but it remains clinically challenging to mitigate the cardi…
Phase 1/2 • Sponsor: Texas Tech University Health Sciences Center • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Could an extra spinal cut straighten scoliosis better?
Disease control CompletedBackground: Posterior column osteotomies (PCO) are routinely used to facilitate curve correction in surgical treatment of adolescent idiopathic scoliosis (AIS). Data regarding routine use of PCO is controversial, with conflicting data for coronal and sagittal plane correction and…
Sponsor: Turku University Hospital • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a Two-Drug combo rewire the PTSD brain?
Disease control Recruiting nowUp-to-date, no studies have examined the attentional, sensory and emotional processing (difficulties) among patients diagnosed with Posttraumatic Stress Disorder (PTSD). In addition, the efficiency of drug treatments that focus on the noradrenergic and dopaminergic, and thus infl…
Phase 2 • Sponsor: University of Haifa • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can an Iron-Based dye reveal hidden inflammation in progressive MS?
Diagnosis CompletedThis pilot study takes the innovative approach of using ultrasmall superparamagnetic iron oxide (USPIO) nanoparticle enhanced MRI to measure activity of the innate immune system within MS lesions. Activity of innate immunity has been hypothesized as one of the critical pathologic…
Early phase 1 • Sponsor: University of Utah • Aim: Diagnosis
Last updated Aug 15, 2026 00:00 UTC
-
Can a blood pressure medication curb cannabis cravings?
Disease control CompletedThe primary purpose of this study is to investigate the effect of guanfacine-ER on reductions in cannabis use and explore its effects on impulsivity and withdrawal through a hybrid in-person and virtual trial of treatment-seeking individuals with Cannabis Use Disorder (CUD), and …
Phase 2 • Sponsor: New York State Psychiatric Institute • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
A simple blood draw might reveal hidden eye lymphoma
Diagnosis CompletedUveitis is an inflammation of the uvea, an ocular tunic comprising the iris, ciliary body and choroid. This inflammation can also involve other tissues such as the retina, the optic nerve and the aqueous humor. These diseases can result in significant vision loss and account for …
Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated Sep 03, 2026 00:00 UTC
-
Could a simple stool test spare thousands from repeat colonoscopies?
Prevention OngoingColorectal cancer (CRC) screening programs have been implemented to reduce the burden of the disease. When an advanced colonic lesions is detected, it is recommended to perform endoscopic surveillance with different intervals between explorations. Although the reduction in CRC in…
Sponsor: Fundacin Biomedica Galicia Sur • Aim: Prevention
Last updated Sep 05, 2026 00:00 UTC
-
Could a bone marrow drug help Alzheimer's patients?
Disease control Recruiting nowA medicine that is FDA-approved for bone marrow stimulation (called sargramostim) will be tested for its safety and efficacy in individuals with mild-to-moderate Alzheimer's disease over a six month treatment period.
Phase 2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New hope for tough leukemia? early trial tests AB8939
Disease control Recruiting nowThe primary objective is to define the safety and tolerability of AB8939 in patients with AML by determining the dose-limiting toxicities, the maximum tolerated dose, and the recommended dose for dose expansion study.
Phase 1/2 • Sponsor: AB Science • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Could a drug combo replace radiation for rectal cancer?
Disease control OngoingThis study is designed as a single-center, phase II exploratory clinical trial to evaluate the pathological response rate and safety of sintilimab (PD-1 inhibitor) combined with XELOX regimen (oxaliplatin + capecitabine) for neoadjuvant treatment of LARC. The study focuses on the…
Phase 2 • Sponsor: The First Affiliated Hospital of Anhui Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New mRNA therapy aims to control blood sugar in rare genetic disease
Disease control OngoingThe main goal of this trial is to evaluate the safety and tolerability of mRNA-3745 via intravenous (IV) administration in adult and pediatric participants with GSD1a.
Phase 1/2 • Sponsor: ModernaTX, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Could a lung scarring drug help ARDS patients breathe easier?
Disease control Recruiting nowAcute respiratory distress syndrome (ARDS) is a severe form of acute lung injury and a major cause of Intensive Care Unit (ICU) admission worldwide. Despite a large number of randomized clinical trials, a specific and effective pharmacological approach for patients with ARDS is s…
Phase 3 • Sponsor: Università Vita-Salute San Raffaele • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Stool transplants via stoma show promise for treating Post-Surgery colon inflammation
Disease control CompletedDiversion colitis (DC) is a common inflammatory complication in patients with temporary ileostomy after rectal cancer surgery, and no standardized medical treatment exists. This prospective, assessor-blinded, parallel-group, randomized controlled trial evaluated whether autologou…
Sponsor: Yongjian Liao • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC